Karachi Sales Presentation

July 21
SALES MEETING JULY 2021

Name of Manager: Kawish Anwer Khan

Region/Area: DFM Rainbow 1 KHI A

 RAINBOW 1
UNITS
Products Actual Estimates Actual Growth % Ach. % Estimates Actual Growth %
Jan-Jun 20 Jan-Jun 21 Jan-Jun 21 2021/2020 Act. / Est. Q3-21 Q3-20 Q3-21/20
D-TRES Inj. 1's 1,974 2,961 3,832 94 129 2,500 1,292 93
D-TRES Inj. 5's 1,070 1,605 2,345 119 146 1,800 852 111
NOVIDAT Tab. 500mg 51,048 63,810 63,235 24 99 36,301 29,041 25
ORNO Inj. 8mg/2ml 2,404 3,606 4,635 93 129 3,000 1,386 116
ORNO Rapid Tab. 8mg 1,167 1,750 2,281 95 130 1,500 622 141
TIMEQUIN Cap. 31 93 103 232 111 103 74 39
TIMEQUIN Sachets 64 83 23 (64) 28 52 37 41
ViD-Tres Oral Drops 96 576 1,091 1,036 189 1,112 278 300

VALUE (+000) 14632 18705 19313 32 103 11569 8547 35

SALES MEETING JULY 2021

Name of Manager: M. Kamran

Region/Area: DFM Rainbow 1 KHI B

 RAINBOW 1
UNITS
Products Actual Estimates Actual Growth % Ach. % Estimates Actual Growth %
Jan-Jun 20 Jan-Jun 21 Jan-Jun 21 2021/2020 Act. / Est. Q3-21 Q3-20 Q3-21/20
D-TRES Inj. 1's 1,458 2,200 4,245 191 193 2,500 989 153
D-TRES Inj. 5's 969 1,450 1,478 53 102 950 654 45
NOVIDAT Tab. 500mg 68,425 84,500 76,015 11 90 46,000 37,174 24
ORNO Inj. 8mg/2ml 545 1,644 1,318 142 80 1,050 208 405
ORNO Rapid Tab. 8mg 1,558 2,550 3,157 103 124 1,650 518 219
TIMEQUIN Cap. 61 100 4 (93) 4 80 20 300
TIMEQUIN Sachets 3 60 22 633 37 40 1 3,900
ViD-Tres Oral Drops 148 2,200 763 416 35 1,250 324 286

VALUE (+000) 18465 24396 21841 18 90 13594 10104 35

SALES MEETING JULY 2021

Name of Manager: Syed Tabish Hussain

Region/Area: DFM Rainbow 1 KHI C

 RAINBOW 1
UNITS
Products Actual Estimates Actual Growth % Ach. % Estimates Actual Growth %
Jan-Jun 20 Jan-Jun 21 Jan-Jun 21 2021/2020 Act. / Est. Q3-21 Q3-20 Q3-21/20
D-TRES Inj. 1's 3,244 5,200 7,137 120 137 4,500 2,445 84
D-TRES Inj. 5's 2,290 3,000 2,823 23 94 2,000 1,420 41
NOVIDAT Tab. 500mg 70,480 86,000 76,671 9 89 46,000 37,438 23
ORNO Inj. 8mg/2ml 2,496 3,500 4,359 75 125 3,200 1,756 82
ORNO Rapid Tab. 8mg 2,756 3,800 4,630 68 122 3,000 1,209 148
TIMEQUIN Cap. 2 90 2 - 2 60 - #DIV/0!
TIMEQUIN Sachets 4 90 2 (50) 2 60 1 5,900
ViD-Tres Oral Drops 112 2,200 1,619 1,346 74 2,000 429 366

VALUE (+000) 20214 26202 23497 16 90 14833 11203 32

SALES MEETING JULY 2021

Name of Manager: M. Rafi

Region/Area: DFM Rainbow 2 KHI A

 RAINBOW 2
UNITS
Products Actual Estimates Actual Growth % Ach. % Estimates Actual Growth %
Jan-Jun 20 Jan-Jun 21 Jan-Jun 21 2021/2020 Act. / Est. Q3-21 Q3-20 Q3-21/20
DULTIX DR Cap. 20mg 101 350 262 159% 75% 200 128 56%
DULTIX DR Cap. 30mg 236 447 339 44% 76% 400 157 155%
DULTIX DR Cap. 40mg -33 100 74 -324% 74% 300 4 7400%
DULTIX DR Cap. 60mg -16 50 41 -356% 82% 250 24 942%
IZATO SUSP. 100mg/5ml 30ml 4664 5300 5139 10% 97% 4000 3343 20%
IZATO SUSP. 100mg/5ml 60ml 152 350 288 89% 82% 222 131 69%
IZATO Tab. 500mg 1286 1500 1239 -4% 83% 850 624 36%
MELOR Tab. 15mg 317 559 332 5% 59% 276 135 104%
MELOR Tab. 7.5mg 468 500 302 -35% 60% 450 305 48%
NOVIDAT DS Inj. 400mg 3485 3800 3590 3% 94% 3550 2837 25%
NOVIDAT Inj. 200mg 24627 28500 26034 6% 91% 18544 14847 25%
NOVIDAT Susp. 125mg 50606 61000 59198 17% 97% 42000 34674 21%
NOVIDAT Susp. 250mg 17651 22183 20559 16% 93% 13000 7805 67%
NOVIDAT Tab. 250mg 56283 66500 64054 14% 96% 38000 30803 23%
NOVOTEpH Cap. 20mg 7101 12500 11579 63% 93% 8000 3530 127%
NOVOTEpH Cap. 40mg 5692 12500 10974 93% 88% 6000 3043 97%
NOVOTEpH Inf. 40mg 1903 4100 3924 106% 96% 2600 1189 119%
SEDIL Syrup 8831 13500 12052 36% 89% 6300 5051 25%
SEDIL Tab. 10mg 5913 12500 11027 86% 88% 6200 4892 27%

VALUE (+000) 24996 34887 32439 30% 93% 20965 14617 43%
SALES MEETING JULY 2021

Name of Manager: Wasif Mehboob

Region/Area: DFM Rainbow 2 KHI B

 RAINBOW 2
UNITS
Products Actual Estimates Actual Growth % Ach. % Estimates Actual Growth %
Jan-Jun 20 Jan-Jun 21 Jan-Jun 21 2021/2020 Act. / Est. Q3-21 Q3-20 Q3-21/20
DULTIX DR Cap. 20mg 3 250 501 16,600 200 400 297 35
DULTIX DR Cap. 30mg 42 250 404 862 162 310 193 61
DULTIX DR Cap. 40mg (55) 250 30 (155) 12 140 17 724
DULTIX DR Cap. 60mg (44) 250 31 (170) 12 100 32 213
IZATO SUSP. 100mg/5ml 30ml 2,021 3,500 2,131 5 61 2,700 1,237 118
IZATO SUSP. 100mg/5ml 60ml 81 250 61 (25) 24 200 45 344
IZATO Tab. 500mg 163 300 151 (7) 50 200 66 203
MELOR Tab. 15mg 681 800 1,470 116 184 800 279 187
MELOR Tab. 7.5mg 139 350 266 91 76 300 99 203
NOVIDAT DS Inj. 400mg 5,219 6,500 5,836 12 90 3,700 2,915 27
NOVIDAT Inj. 200mg 27,095 32,000 30,422 12 95 21,000 16,533 27
NOVIDAT Susp. 125mg 55,121 66,000 65,468 19 99 45,000 36,564 23
NOVIDAT Susp. 250mg 20,128 24,000 20,753 3 86 12,035 9,252 30
NOVIDAT Tab. 250mg 73,660 85,000 81,478 11 96 52,000 42,871 21
NOVOTEpH Cap. 20mg 4,316 8,500 7,632 77 90 4,300 2,028 112
NOVOTEpH Cap. 40mg 4,169 12,000 11,000 164 92 7,000 2,257 210
NOVOTEpH Inf. 40mg 712 2,500 3,253 357 130 2,000 199 905
SEDIL Syrup 7,206 11,000 7,562 5 69 5,000 3,936 27
SEDIL Tab. 10mg 6,167 9,000 8,567 39 95 5,200 4,107 27

VALUE (+000) 27198 37358 31792 17 85 23029 16707 38

SALES MEETING JULY 2021

Name of Manager: Vacant

Region/Area: DFM Rainbow 2 KHI C
 RAINBOW 2
UNITS
Products Actual Estimates Actual Growth % Ach. % Estimates Actual Growth %
Jan-Jun 20 Jan-Jun 21 Jan-Jun 21 2021/2020 Act. / Est. Q3-21 Q3-20 Q3-21/20
DULTIX DR Cap. 20mg 206 453 91 (56) 20 250 127 97
DULTIX DR Cap. 30mg 221 447 376 70 84 400 99 304
DULTIX DR Cap. 40mg (53) 23 23 (143) 100 200 - #VALUE!
DULTIX DR Cap. 60mg (46) 27 20 (143) 74 200 7 2,757
IZATO SUSP. 100mg/5ml 30ml 3,134 5,000 3,848 23 77 2,700 2,036 33
IZATO SUSP. 100mg/5ml 60ml 342 427 790 131 185 400 136 194
IZATO Tab. 500mg 157 1,500 470 199 31 400 104 285
MELOR Tab. 15mg 104 559 348 235 62 250 27 826
MELOR Tab. 7.5mg 121 600 286 136 48 300 47 538
NOVIDAT DS Inj. 400mg 4,739 6,492 5,134 8 79 3,500 2,638 33
NOVIDAT Inj. 200mg 24,123 34,025 30,668 27 90 23,000 18,167 27
NOVIDAT Susp. 125mg 53,605 65,000 61,394 15 94 46,000 38,389 20
NOVIDAT Susp. 250mg 19,286 24,000 20,236 5 84 11,000 8,651 27
NOVIDAT Tab. 250mg 65,230 75,000 68,075 4 91 45,000 36,273 24
NOVOTEpH Cap. 20mg 4,687 4,959 6,120 31 123 4,200 2,376 77
NOVOTEpH Cap. 40mg 5,744 8,553 10,681 86 125 7,000 2,460 185
NOVOTEpH Inf. 40mg 1,681 2,427 3,606 115 149 2,500 599 317
SEDIL Syrup 5,816 12,500 6,560 13 52 4,000 2,848 40
SEDIL Tab. 10mg 6,033 9,260 6,136 2 66 4,700 3,604 30

VALUE (+000) 25906 35711 32413 25 91 22390 15442 45

SALES MEETING JULY 2021

Name of Manager: M. Aneeqe

Region/Area: DFM Rainbow 3 KHI A
 RAINBOW 3
UNITS
Products Actual Estimates Actual Growth % Ach. % Estimates Actual Growth %
Jan-Jun 20 Jan-Jun 21 Jan-Jun 21 2021/2020 Act. / Est. Q3-21 Q3-20 Q3-21/20
BISLERI S Inj. 100mg 5's 1,474 2,400 2,234 52 93 1,800 1,287 40
BISLERI Tab. 3,542 5,500 5,911 67 107 3,750 2,472 52
BREEKY Tab. 200mcg 10,868 20,000 15,121 39 76 10,000 7,105 41
DOCTILE Sachet 3g 30's 39 200 27 (31) 14 150 77 95
FUNGONE Cap. 150mg 3,936 7,600 6,564 67 86 4,000 2,939 36
NIVADOR Inj. 1g 84 300 204 143 68 200 49 308
NIVADOR Inj. 250mg 1,021 2,000 2,194 115 110 1,500 447 236
NIVADOR Inj. 500mg 784 1,000 879 12 88 500 288 74
QUADRO Tab. 300mcg 3 - - #VALUE! #VALUE! - - #VALUE!
QUADRO Tab. 600mcg 21 - - #VALUE! #VALUE! - - #VALUE!
SAMBRO Tab. 3mg 7,743 15,000 10,910 41 73 6,500 4,162 56
SILDAT Cap. 4mg - 500 126 #VALUE! 25 350 21 1,567
SILDAT Cap. 8mg - 500 202 #VALUE! 40 700 23 2,943
TONOFLEX - P Tab. 36,152 56,000 47,130 30 84 30,000 20,179 49
TONOFLEX-P FORTE Tab. 38 200 - #VALUE! #VALUE! 100 15 567
XYQUIL DR Tab. 3,784 5,500 5,576 47 101 3,000 2,412 24

VALUE (+000) 9505 17387 15087 59 87 10357 6218 67

SALES MEETING JULY 2021

Name of Manager: M. Jamil

Region/Area: DFM Rainbow 3 KHI B
 RAINBOW 3
UNITS
Products Actual Estimates Actual Growth % Ach. % Estimates Actual Growth %
Jan-Jun 20 Jan-Jun 21 Jan-Jun 21 2021/2020 Act. / Est. Q3-21 Q3-20 Q3-21/20
BISLERI S Inj. 100mg 5's 746 1,400 1,061 42 76 1,000 507 97
BISLERI Tab. 2,957 4,000 4,203 42 105 2,500 1,233 103
BREEKY Tab. 200mcg 14,910 16,000 17,194 15 107 10,000 8,281 21
DOCTILE Sachet 3g 30's 103 200 185 80 93 150 43 249
FUNGONE Cap. 150mg 5,359 8,300 7,401 38 89 4,500 2,955 52
NIVADOR Inj. 1g 334 500 868 160 174 550 185 197
NIVADOR Inj. 250mg 1,301 2,000 1,372 5 69 800 370 116
NIVADOR Inj. 500mg 1,302 1,400 870 (33) 62 600 242 148
QUADRO Tab. 300mcg 18 - - #VALUE! #VALUE! - - #VALUE!
QUADRO Tab. 600mcg 35 - - #VALUE! #VALUE! - #VALUE!
SAMBRO Tab. 3mg 13,204 15,000 17,027 29 114 9,500 7,240 31
SILDAT Cap. 4mg - 500 128 #VALUE! 26 250 - #VALUE!
SILDAT Cap. 8mg - 500 136 #VALUE! 27 250 - #VALUE!
TONOFLEX - P Tab. 42,839 56,000 56,132 31 100 36,000 22,679 59
TONOFLEX-P FORTE Tab. 138 200 6 (96) 3 100 51 96
XYQUIL DR Tab. 3,342 5,500 4,914 47 89 3,200 2,606 23

VALUE (+000) 10656 15668 14736 38 94 9909 5887 68

SALES MEETING JULY 2021

Name of Manager: M. Farukh

Region/Area: DFM Rainbow 3 KHI C
 RAINBOW 3
UNITS
Products Actual Estimates Actual Growth % Ach. % Estimates Actual Growth %
Jan-Jun 20 Jan-Jun 21 Jan-Jun 21 2021/2020 Act. / Est. Q3-21 Q3-20 Q3-21/20
BISLERI S Inj. 100mg 5's 1,385 2,600 2,724 97 105 1,800 1,002 80
BISLERI Tab. 4,708 6,600 7,329 56 111 4,500 2,776 62
BREEKY Tab. 200mcg 17,581 20,000 17,844 1 89 11,000 9,583 15
DOCTILE Sachet 3g 30's 132 200 137 4 69 150 71 111
FUNGONE Cap. 150mg 7,826 9,000 10,029 28 111 6,500 5,166 26
NIVADOR Inj. 1g 20 300 649 3,145 216 400 47 751
NIVADOR Inj. 250mg 608 1,500 2,594 327 173 1,600 450 256
NIVADOR Inj. 500mg 151 - 824 446 #VALUE! 700 143 390
QUADRO Tab. 300mcg 19 - - #VALUE! #VALUE! - - #VALUE!
QUADRO Tab. 600mcg 28 - #VALUE! #VALUE! - - #VALUE!
SAMBRO Tab. 3mg 10,928 15,000 13,444 23 90 7,500 5,755 30
SILDAT Cap. 4mg - 500 141 #VALUE! 28 500 - #VALUE!
SILDAT Cap. 8mg - 500 284 #VALUE! 57 500 - #VALUE!
TONOFLEX - P Tab. 38,687 56,000 47,761 23 85 30,000 19,879 51
TONOFLEX-P FORTE Tab. 200 250 161 (20) 64 150 116 29
XYQUIL DR Tab. 3,314 5,500 3,732 13 68 2,700 2,135 26

VALUE (+000) 11348 17779 16819 48 95 10668 6592 62

SALES MEETING JULY 2021

Name of Manager: Mehtab Mazahir

Region/Area: DFM Rainbow 4 KHI A
 Products Actual Estimates Actual Growth % Ach. % Estimates Actual Growth %
Jan-Jun 20 Jan-Jun 21 Jan-Jun 21 2021/2020 Act. / Est. Q3-21 Q3-20 Q3-21/20
ABACUS Susp. 100mg/5ml 90 238 143 59 60 100 76 32
ABACUS Susp. 40mg/5ml 167 1200 1408 743 117 295 80 269
ABACUS Tab. 100mg 100 307 98 -2 32 100 70 43
ABACUS Tab. 200mg 14 106 61 336 58 100 37 170
BECEPTOR Tab. 10mg 390 2376 2263 480 95 1500 447 236
BECEPTOR Tab. 20mg 73 650 531 627 82 500 133 276
BISLERI Cap. 340 1200 1292 280 108 750 172 336
BISLERI Syp. 120 303 450 412 36 92 300 147 104
BISLERI Syp. 60 3779 4500 4162 10 92 2500 2036 23
GRASIL Inj. 100 mg 27601 37805 26119 -5 69 19500 15949 22
GRASIL Inj. 25 mg 5's 3692 5538 4689 27 85 4400 3478 27
GRASIL Inj. 250 mg 3845 5798 3601 -6 62 2500 1783 40
GRASIL Inj. 50 mg 5's 5937 6722 6629 12 99 5100 4074 25
GRASIL Inj. 500 mg 4496 6657 4429 -1 67 2700 1859 45
INTIG D Susp. 1983 4135 4027 103 97 2393 1526 57
INTIG D Tab. 1869 4000 3800 103 95 2200 1485 48
INTIG-D Susp. 120ml 19 150 118 521 79 80 14 471
LAGITA Adv ance Susp 10134 18000 20604 103 114 12000 5044 138
LAGITA Adv ance Tab. 140 246 233 66 95 350 115 204
MOVERYL Cap. 100mg 21 99 73 248 74 100 18 456
MOVERYL Cap. 200mg 14 31 9 -36 29 100 0 0
TAMISO MR Cap. 0.4mg 758 945 402 -47 43 500 385 30

VALUE (+000)
8495 13314 11193 32 84 7635 5067 51
7572471.9
SALES MEETING JULY 2021

Name of Manager: M. Arsalan

Region/Area: DFM Rainbow 4 KHI B
 Products Actual Estimates Actual Growth % Ach. % Estimates Actual Growth %
Jan-Jun 20 Jan-Jun 21 Jan-Jun 21 2021/2020 Act. / Est. Q3-21 Q3-20 Q3-21/20
ABACUS Susp. 100mg/5ml 44 207 44 0 21 100 33 203
ABACUS Susp. 40mg/5ml 324 727 399 23 55 250 131 91
ABACUS Tab. 100mg 193 222 107 -45 48 150 91 65
ABACUS Tab. 200mg -1 70 57 -5800 81 34 0 #DIV/0!
BECEPTOR Tab. 10mg 450 1600 1157 157 72 1500 492 205
BECEPTOR Tab. 20mg 7 390 97 1286 25 500 65 669
BISLERI Cap. 444 800 894 101 112 550 172 220
BISLERI Syp. 120 287 409 365 27 89 300 159 89
BISLERI Syp. 60 1719 3821 3037 77 79 1700 962 77
GRASIL Inj. 100 mg 31962 37810 29459 -8 78 22000 17818 23
GRASIL Inj. 25 mg 5's 2183 4000 2646 21 66 3000 2213 36
GRASIL Inj. 250 mg 4947 6537 6070 23 93 3239 2797 16
GRASIL Inj. 50 mg 5's 2633 4000 2993 14 75 2700 1655 63
GRASIL Inj. 500 mg 8162 10600 10639 30 100 6000 4108 46
INTIG D Susp. 2811 3993 2857 2 72 1850 1330 39
INTIG D Tab. 2262 3182 3569 58 112 1900 1176 62
INTIG-D Susp. 120ml 137 220 216 58 98 180 106 70
LAGITA Adv ance Susp 5693 11266 11742 106 104 7000 2789 151
LAGITA Adv ance Tab. 305 206 180 -41 87 250 118 112
MOVERYL Cap. 100mg 35 83 13 -63 16 100 2 4900
MOVERYL Cap. 200mg 2 32 3 50 9 100 -7 -1529
TAMISO MR Cap. 0.4mg 799 1011 436 -45 43 500 314 59

VALUE (+000)
8711 12232 10532 21 86 7242 4805 51
7270224.5
SALES MEETING JULY 2021

Name of Manager: Ajmal Ali

Region/Area: DFM Rainbow 4 KHI C
 RAINBOW 4
UNITS
Products Actual Estimates Actual Growth % Ach. % Estimates Actual Growth %
Jan-Jun 20 Jan-Jun 21 Jan-Jun 21 2021/2020 Act. / Est. Q3-21 Q3-20 Q3-21/20
ABACUS Susp. 100mg/5ml 91 207 138 52 67 100 54 85
ABACUS Susp. 40mg/5ml 640 1600 1771 177 111 900 384 134
ABACUS Tab. 100mg 104 500 487 368 97 250 44 468
ABACUS Tab. 200mg 7 120 108 1443 90 60 12 400
BECEPTOR Tab. 10mg 862 3200 3419 297 107 2000 861 132
BECEPTOR Tab. 20mg 1 390 -74 -7500 -19 250 80 213
BISLERI Cap. 383 622 781 104 126 400 256 56
BISLERI Syp. 120 276 409 293 6 72 262 178 47
BISLERI Syp. 60 1748 3821 2991 71 78 1800 1380 30
GRASIL Inj. 100 mg 26444 37810 23998 -9 63 20000 16101 24
GRASIL Inj. 25 mg 5's 4544 5435 5153 13 95 4200 3356 25
GRASIL Inj. 250 mg 3543 6537 3993 13 61 2700 2095 29
GRASIL Inj. 50 mg 5's 3831 5986 5549 45 93 3300 2751 20
GRASIL Inj. 500 mg 6654 7900 7450 12 94 4500 3379 33
INTIG D Susp. 2728 3993 3989 46 100 2350 1839 28
INTIG D Tab. 2017 3182 3449 71 108 1900 1050 81
INTIG-D Susp. 120ml 88 150 137 56 91 90 44 105
LAGITA Adv ance Susp 6740 11266 13172 95 117 7200 3745 92
LAGITA Adv ance Tab. 246 350 187 -24 53 250 171 46
MOVERYL Cap. 100mg 50 83 77 54 93 100 28 257
MOVERYL Cap. 200mg 5 32 0 -100 0 100 0 #DIV/0!
TAMISO MR Cap. 0.4mg 611 1011 375 -39 37 400 247 62

VALUE (+000)
7208 11178 9268 29 83 5954 4242 40